Role of microRNA in Normal and Malignant Hematopoiesis

  • Ruchi Gupta
  • Khaliqur Rahman


Epigenetic modifications in the recent era have received a lot of attention in a variety of diseases particularly cancer. They are defined as the modulation of gene expression by chromatin modification that does not involve DNA sequence alterations [1]. These modifications act either by altering the chromatin structure to deregulate gene expression or by the post-translational modification. Consequently, epigenetics control cell differentiation and function by “switching on” or “off” certain gene expressions, and a disruption of the normal epigenetic mechanism can lead to uncontrolled gene activation or silencing resulting into an altered homeostasis. Three main types of epigenetic processes which have been identified include DNA methylation, nucleosomal histone modifications, and post-translational alterations by the non-coding RNAs [2]. Prominent among these non-coding RNAs are microRNAs (miRNAs), which have recently emerged as important players in the regulation of normal hematopoietic cell development and differentiation as well as in malignant transformation. In this chapter, we have provided a comprehensive summary of the current knowledge on the role of miRNAs in normal and aberrant hematopoiesis with a focus on the clinical significance of the deranged miRNAs in some of the common hematological neoplasms.


microRNA Normal hematopoiesis Leukemias 


  1. 1.
    Weinhold B. Epigenetics: the science of change. Environ Health Perspect. 2006;114(3):A160–7.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Rice KL, Hormaeche I, Licht JD. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene. 2007;26(47):6697–714.PubMedCrossRefGoogle Scholar
  3. 3.
    Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–54.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642–55.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics. 2014;2014:970607.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(Database issue):D140–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Vasudevan S. Posttranscriptional upregulation by microRNAs. Wiley Interdiscip Rev RNA. 2012;3(3):311–30.PubMedCrossRefGoogle Scholar
  8. 8.
    Hong SH, Kim KS, Oh IH. Concise review: exploring miRNAs—toward a better understanding of hematopoiesis. Stem Cells. 2015;33(1):1–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Guo S, Lu J, Schlanger R, Zhang H, Wang JY, Fox MC, et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc Natl Acad Sci U S A. 2010;107:14229–34.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, et al. Dicer is essential for mouse development. Nat Genet. 2003;35(3):215–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Kotaki R, Koyama-Nasu R, Yamakawa N, Kotani A. miRNAs in normal and malignant hematopoiesis. Int J Mol Sci. 2017;18(7):1495.PubMedCentralCrossRefGoogle Scholar
  12. 12.
    Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small library sequencing. Cell. 2007;129:1401–14.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Petriv OI, Kuchenbauer F, Delaney AD, Lecault V, White A, Kent D, et al. Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A. 2010;107(35):15443–8.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Georgantas RW III, Hildreth R, Morisot S, Alder J, Liu C-g, Heimfeld S, et al. CD34+ hematopoietic stem progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007;104(8):2750–5.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Bissels U, Wild S, Tomiuk S, Hafner M, Scheel H, Mihailovic A, et al. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Stem Cells. 2011;29:847–57.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Bhagavathi S, Czader M. MicroRNAs in benign and malignant hematopoiesis. Arch Pathol Lab Med. 2010;134:1276–81.PubMedGoogle Scholar
  17. 17.
    Pelosi E, et al. MicroRNAs in normal and malignant myelopoiesis. Leuk Res. 2009;33:1584–93.PubMedCrossRefGoogle Scholar
  18. 18.
    Mukai HY, Motohashi H, Ohmeda O, Suzuki N, Nagano M, Yamamoto M. Transgene insertion in proximity to thr c-myb gene disrupts erythroid megakaryocytic lineage bifurcation. Mol Cell Biol. 2006;26:7953–65.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. The regulated expression of miRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol. 2007;35(11):1657–67.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Lisio LD, Martinez N, Montes-Moreno S, Piris-Villaespesa M, Sanchez-Beato M, Piris MA. The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas. Blood. 2012;120(9):1782–90.PubMedCrossRefGoogle Scholar
  21. 21.
    Johanson TM, Skinner JPJ, Kumar A, et al. The role of microRNAs in lymphopoiesis. Int J Hematol. 2014;100:246.PubMedCrossRefGoogle Scholar
  22. 22.
    Zhang J, Jima DD, Jacobs C, et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood. 2009;113(19):4586–94.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Ghisi M, Corradin A, Basso K, Frasson C, Serafin V, Mukherjee S, et al. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood. 2011;117:7053–62.PubMedCrossRefGoogle Scholar
  24. 24.
    Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147–61.PubMedCrossRefGoogle Scholar
  25. 25.
    Lagana A, Russo F, Sismeiro C, Giugno R, Pulvirenti A, Ferro A. Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material. PLoS One. 2010;5(6):e11166.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99(24):15524–9.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Zenz T, Mohr J, Eldering E, et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood. 2009;113:3801–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Deshpande A, Pastore A, Deshpande AJ, Zimmermann Y, Hutter G, Weinkauf M, et al. 3’UTR mediated regulation of the cyclin D1 protooncogene. Cell Cycle. 2009;8(21):3592–600.PubMedCrossRefGoogle Scholar
  29. 29.
    Wang W, Corrigan-Cummins M, Hudson J, Maric I, Simakova O, Neelapu SS, et al. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica. 2012;97(4):586–94.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, et al. Microrna expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007;121:1156–61.PubMedCrossRefGoogle Scholar
  31. 31.
    Ni H, Tong R, Zou L, Song G, Cho WC. MicroRNAs in diffuse large B-cell lymphoma. Oncol Lett. 2016;11(2):1271–80.PubMedCrossRefGoogle Scholar
  32. 32.
    Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A. 2008;105(35):12885–90.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Seckinger A, Meißner T, Moreaux J, Benes V, Hillengass J, Castoldi M, et al. miRNAs in multiple myeloma—a survival relevant complex regulator of gene expression. Oncotarget. 2015;6(36):39165–83.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Rossi M, Tagliaferri P, Tassone P. MicroRNAs in multiple myeloma and related bone disease. Ann Transl Med. 2015;3(21):334.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Starczynowski DT, Morin R, McPherson A, Lam J, Chari R, Wegrzyn J, et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood. 2011;117(2):595–607.PubMedCrossRefGoogle Scholar
  36. 36.
    Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, et al. Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br J Haematol. 2011;153(1):24–32.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Pons A, Nomdedeu B, Navarro A, Gaya A, Gel B, Diaz T, et al. Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma. 2009;50:1854–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Hussein K, Theophile K, Büsche G, Schlegelberger B, Göhring G, Kreipe H, et al. Aberrant microRNA expression pattern in myelodysplastic bone marrow cells. Leuk Res. 2010;34(9):1169–74.PubMedCrossRefGoogle Scholar
  39. 39.
    Song SJ, Pandolfi PP. MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemia. Curr Opin Hematol. 2014;21(4):276–82.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Scholl S, Fricke HJ, Sayer HG, Hoffken K. Clinical implications of molecular genetic aberrations in acute myeloid leukemia. J Cancer Res Clin Oncol. 2009;135:491–505.PubMedCrossRefGoogle Scholar
  41. 41.
    Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008;111(6):3183–9.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Wang Y, Li Z, He C, Wang D, Yuan X, Chen J, et al. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Blood Cells Mol Dis. 2010;44(3):191–7.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    de Oliveira JC, Scrideli CA, Brassesco MS, Morales AG, Pezuk JA, Queiroz Rde P, et al. Differential miRNA expression in childhood ALL and association with clinical and biological features. Leuk Res. 2012;36(3):293–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Schotte D, De Menezes RX, Akbari Moqadam F, Khankahdani LM, Lange-Turenhout E, Chen C, et al. MicroRNA characterizes genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica. 2011;96(5):703–11.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Sanghvi VR, Mavrakis KJ, Van der Meulen J, Boice M, Wolfe AL, Carty M, et al. Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia. Sci Signal. 2014;7(352):ra111.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Saki N, Abroun S, Soleimani M, Hajizamani S, Shahjahani M, Kast RE, et al. Involvement of microRNA in T-cell differentiation and malignancy. Int J Hematol Oncol Stem Cell Res. 2015;9(1):33–49.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU, et al. Expression of the miR-17- 92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood. 2007;109(10):4399–405.PubMedCrossRefGoogle Scholar
  48. 48.
    San José-Enériz E, Román-Gómez J, Jiménez-Velasco A, Garate L, Martin V, Cordeu L, et al. MicroRNA expression profiling in imatinib-resistant chronic myeloid leukemia patients without clinically significant ABL1-mutations. Mol Cancer. 2009;8(1):69.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    de Planell-Saguer M, Rodicio MC. Detection methods for microRNAs in clinic practice. Clin Biochem. 2013;46(10–11):869–78.PubMedCrossRefGoogle Scholar
  50. 50.
    Baker M. MicroRNA profiling: separating signal from noise. Nat Methods. 2010;7(9):687–92.PubMedCrossRefGoogle Scholar
  51. 51.
    Ciccone M, Calin GA. MicroRNAs in myeloid hematological malignancies. Curr Genomics. 2015;16(5):336–48.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Ruchi Gupta
    • 1
  • Khaliqur Rahman
    • 1
  1. 1.Department of HematologySanjay Gandhi Post Graduate Institute of Medical SciencesLucknowIndia

Personalised recommendations